What is Competitive Landscape of AngioDynamics Company?

AngioDynamics Bundle

Get Full Bundle:

	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

What is the Competitive Landscape of AngioDynamics?

AngioDynamics operates in a competitive medical technology sector focused on minimally invasive solutions. The company has strategically refined its offerings to concentrate on high-growth areas within MedTech.

With a market capitalization around $350-$384 million as of August 2025, AngioDynamics is a notable entity in specialized medical devices. Its technologies are vital for treating conditions like peripheral vascular disease and oncology.

Understanding the competitive environment is key to grasping AngioDynamics' market position. This includes analyzing its rivals, strengths, and the overarching industry trends. A detailed AngioDynamics Porter's Five Forces Analysis can illuminate these dynamics.

AngioDynamics operates within specific segments of the medical device industry, focusing on peripheral vascular, oncology, and vascular access. While precise overall market share data is not publicly detailed, the company is recognized as a notable player in its specialized fields. The peripheral vascular devices market is substantial, projected to reach USD 13.51 billion in 2025, with an anticipated growth rate of 6.5% annually through 2032, indicating a significant market opportunity for AngioDynamics' products.

MedTech Segment Performance

In the fourth quarter of fiscal year 2025, AngioDynamics' MedTech segment achieved net sales of $35.8 million, marking a 22% increase year-over-year. This growth was primarily fueled by the Auryon peripheral atherectomy platform and the thrombus management systems.

Med Device Segment Contribution

The Med Device segment, which includes angiographic catheters and drainage catheters, generated $44.4 million in net sales for Q4 FY25. This represents a 6.2% increase compared to the previous year, demonstrating steady performance in its foundational product lines.

Geographic Revenue Distribution

The United States remains AngioDynamics' primary market, with Q4 FY25 U.S. net sales reaching $67.5 million, an 11.0% rise year-over-year. International sales also showed robust growth, increasing by 22.8% to $12.7 million in the same period.

Strategic Portfolio Realignment

AngioDynamics has strategically divested non-core assets, including its Dialysis and BioSentry portfolios in June 2023 and its PICC and Midline product lines in February 2024. This focus aims to concentrate on higher-growth, higher-margin MedTech solutions.

Financially, for the full fiscal year 2025, AngioDynamics reported net sales of $292.7 million, an increase of 8.1% on a pro forma basis. The company also successfully narrowed its GAAP net loss to $34.0 million from $184.3 million in FY24. In the fourth quarter of fiscal year 2025, adjusted EBITDA was $3.4 million. Despite a current negative EPS of -$0.83, the company's strategic direction and performance improvements are noted by analysts, with an average target price of $18.25 for its stock, reflecting an optimistic outlook on its Target Market of AngioDynamics and future growth potential.

Key Financial and Operational Highlights (FY25 Q4)

AngioDynamics demonstrated significant year-over-year growth in its MedTech segment, driven by key product lines. The company's strategic focus on high-growth areas and divestiture of non-core assets are shaping its market position.

• MedTech Net Sales: $35.8 million (up 22% YoY)
• Auryon Sales: $15.6 million (up 19.7% YoY)
• Mechanical Thrombectomy Revenue: $11.3 million (up 44.7% YoY)
• Med Device Net Sales: $44.4 million (up 6.2% YoY)
• U.S. Net Sales: $67.5 million (up 11.0% YoY)
• International Net Sales: $12.7 million (up 22.8% YoY)
• Full-Year FY25 Net Sales: $292.7 million (up 8.1% pro forma)
• Q4 FY25 Adjusted EBITDA: $3.4 million

AngioDynamics SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

AngioDynamics operates within the dynamic medical device sector, facing a competitive environment populated by both large, established corporations and niche, specialized companies. Its primary areas of competition include peripheral vascular disease, oncology, and vascular access solutions. Understanding the AngioDynamics competitive landscape requires an analysis of these key players.

Major global medical technology companies like Medtronic, Boston Scientific, Becton Dickinson (BD), and Johnson & Johnson represent significant rivals. These entities possess extensive product portfolios, substantial research and development budgets, and well-established global distribution networks. Other notable competitors include Cook Medical, Merit Medical Systems, Terumo Medical Corporation, Teleflex, Argon Medical Devices, and Inari Medical. These companies employ strategies such as competitive pricing, continuous product innovation, strong brand recognition, and robust distribution channels to vie for market share. For instance, Medtronic and Boston Scientific are particularly active in the vascular access and peripheral vascular disease markets, directly challenging AngioDynamics' offerings. In the critical area of thrombus management, companies like Inari Medical are also key players.

Global Medical Technology Giants

Companies such as Medtronic, Boston Scientific, BD, and Johnson & Johnson offer broad product lines and significant R&D investment.

Specialized Competitors

Firms like Cook Medical, Merit Medical Systems, and Inari Medical focus on specific niches, presenting targeted competition.

Competitive Strategies

Rivals compete through aggressive pricing, innovation, brand strength, and established distribution networks.

Market Consolidation Trends

Industry consolidation, seen in acquisitions like Johnson & Johnson's purchase of Shockwave Medical in 2024, reshapes the competitive landscape.

Innovation as a Differentiator

Emerging players and technological advancements necessitate continuous innovation to maintain a competitive edge.

Key Market Segments

Competition is particularly intense in peripheral vascular disease, oncology, and vascular access markets.

AngioDynamics' Market Position and Strategic Considerations

The AngioDynamics market analysis reveals a landscape where strategic agility is paramount. While the company has focused on streamlining its business through divestitures, its last acquisition was in 2019. This contrasts with the aggressive acquisition strategies of larger competitors, highlighting a different approach to growth and market expansion. The company's ability to innovate and adapt to new technologies is crucial for its continued success and to maintain its market position against rivals who are actively consolidating and expanding their portfolios. Understanding the Growth Strategy of AngioDynamics provides further insight into how the company navigates these competitive pressures.

• Major competitors include Medtronic, Boston Scientific, BD, Johnson & Johnson, Cook Medical, Merit Medical Systems, Terumo Medical Corporation, Teleflex, Argon Medical Devices, and Inari Medical.
• Key competitive strategies involve pricing, innovation, brand recognition, and distribution networks.
• Industry consolidation, exemplified by recent major acquisitions, is a significant trend impacting the competitive environment.
• Emerging players and technological advancements require continuous adaptation and innovation from AngioDynamics.
• The company's last acquisition was in 2019, while competitors have been more active in M&A in 2024.

AngioDynamics PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

AngioDynamics has carved out a distinct position in the medical device sector through its proprietary technologies and a focused innovation strategy. The company's competitive edge is significantly bolstered by its specialized portfolio, which includes advanced solutions for peripheral vascular disease and oncology. This strategic focus allows for deeper market penetration and stronger customer relationships.

Key to its competitive landscape analysis, AngioDynamics leverages its Auryon peripheral atherectomy platform and the AlphaVac and AngioVac mechanical thrombectomy systems. These offerings address critical unmet patient needs in treating peripheral arterial disease. Furthermore, the NanoKnife irreversible electroporation platform is a significant differentiator in the oncology space, particularly for prostate and liver lesions.

Proprietary Technology Portfolio

AngioDynamics' competitive advantages are rooted in its specialized MedTech portfolio. This includes the Auryon peripheral atherectomy platform and the AlphaVac and AngioVac mechanical thrombectomy systems, offering minimally invasive solutions for critical patient needs.

Regulatory and Reimbursement Advancements

The NanoKnife system's FDA 510(k) clearance for prostate tissue ablation in December 2024 and the securing of CPT Category I Codes for irreversible electroporation (IRE) effective January 1, 2026, are crucial for market adoption and competitive positioning.

Product Enhancements and Market Penetration

The FDA clearance of the Auryon XL Catheter in January 2024 enhances the Auryon Atherectomy System's capabilities for treating severe peripheral arterial disease, directly impacting its market penetration in interventional oncology and vascular access markets.

Strategic Focus and Customer Relationships

Continuous investment in R&D and strong relationships with healthcare providers are key. Strategic divestitures have streamlined the company's focus on high-growth platforms, reinforcing its market position against major rivals.

Sustaining Competitive Edge

AngioDynamics' competitive advantages are built on its innovative technologies and strategic market approach. The company's commitment to innovation and customer relationships is central to its ability to compete effectively in the dynamic medical device market.

• Proprietary technologies like NanoKnife and Auryon
• FDA clearances and CPT code advancements
• Focus on minimally invasive solutions
• Strong customer relationships and R&D investment
• Strategic portfolio streamlining

AngioDynamics Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

The medical device sector, where AngioDynamics operates, is shaped by significant forces. These include a growing global demand for less invasive medical procedures, constant technological advancements, and the increasing incidence of chronic conditions like cancer and peripheral vascular disease. An aging global population further amplifies the need for sophisticated medical treatments and therapies. These dynamics present both considerable challenges and substantial opportunities for companies within this space.

Understanding the AngioDynamics competitive landscape requires an analysis of these overarching industry trends. The company's market analysis reveals a sector driven by innovation and patient outcomes. Key players are constantly vying for market share through product development and strategic positioning.

Industry Trends Driving Growth

The medical device industry is experiencing a surge in demand for minimally invasive procedures, driven by patient preference for faster recovery and shorter hospital stays. Technological innovation is paramount, with companies investing heavily in R&D to develop next-generation devices. The rising prevalence of chronic diseases globally, coupled with an aging demographic, creates a sustained need for advanced medical solutions.

Anticipated Disruptions and Challenges

Companies face intense competition and evolving regulatory landscapes. Economic uncertainties can impact capital spending on new technologies. For instance, a tariff impact of $1.6 million was noted in Q4 fiscal year 2025, affecting gross margins. Negative free cash flow, such as the -$3.5 million reported, highlights the importance of robust cash management strategies. Consolidation through mergers and acquisitions by larger entities also reshapes market dynamics.

Key Growth Opportunities

The increasing adoption of minimally invasive techniques aligns perfectly with the company's product portfolio. Emerging markets offer significant expansion potential due to improving healthcare infrastructure and growing demand for advanced medical technologies. Strategic product focus on systems like NanoKnife for prostate cancer and Auryon for peripheral artery disease (PAD) is a key growth driver.

Strategic Outlook and Market Position

The company has repositioned itself as a profitable, growth-oriented entity targeting a global market opportunity exceeding $10 billion. Fiscal year 2026 guidance projects 4-6% net sales growth, with MedTech sales anticipated to increase by 12-15%. This indicates a strategic shift towards high-growth segments and operational efficiency to maintain resilience.

Competitive Advantages and Strategies

The company's competitive advantages lie in its innovative product pipeline and strategic focus on high-growth areas within the medical device market. Its strategies aim to capitalize on the expanding demand for minimally invasive procedures and penetrate emerging markets effectively. Understanding the Revenue Streams & Business Model of AngioDynamics provides further insight into its market position and operational approach.

• Focus on minimally invasive procedures
• Expansion into emerging markets
• Innovation in key product platforms (e.g., NanoKnife, Auryon)
• Strategic repositioning for growth and profitability

AngioDynamics Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔